Sutro Biopharma

$17.34
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.60 (+3.64%) Today
+$0.24 (+1.40%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell STRO and other stocks, options, and ETFs commission-free!

About STRO

Sutro Biopharma Inc. engages in the drug discovery, development, and manufacturing of pharmaceutical products. It focuses on next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA. The listed name for STRO is Sutro Biopharma, Inc. Common Stock.

CEO
William J. Newell
Employees
168
Headquarters
South San Francisco, California
Founded
2003
Market Cap
660.13M
Price-Earnings Ratio
Dividend Yield
Average Volume
336.07K
High Today
$17.38
Low Today
$16.56
Open Price
$16.61
Volume
585.99K
52 Week High
$19.19
52 Week Low
$6.00

Collections

STRO Earnings

-$0.84
-$0.41
$0.02
$0.45
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 16, Pre-Market

You May Also Like